Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $368.00 | 14 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $206.72 | 6 | $0 (2023) |
| Merck Sharp & Dohme LLC | $48.40 | 2 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $48.12 | 3 | $0 (2022) |
| Boston Scientific Corporation | $25.04 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $21.77 | 1 | $0 (2023) |
| ABBVIE INC. | $17.95 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $130.29 | 6 | Merck Sharp & Dohme LLC ($48.40) |
| 2022 | $84.41 | 5 | AstraZeneca Pharmaceuticals LP ($48.76) |
| 2021 | $46.59 | 1 | AstraZeneca Pharmaceuticals LP ($46.59) |
| 2020 | $12.47 | 1 | E.R. Squibb & Sons, L.L.C. ($12.47) |
| 2017 | $94.24 | 1 | AstraZeneca Pharmaceuticals LP ($94.24) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/19/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/22/2023 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/21/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/11/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/28/2023 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: WATCHMAN_IC | ||||||
| 03/16/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $29.05 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/22/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/29/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.01 | General |
| Category: Cardiovascular | ||||||
| 06/30/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.64 | General |
| Category: Cardiovascular | ||||||
| 06/16/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/27/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/14/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $46.59 | General |
| Category: Respiratory | ||||||
| 09/18/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.47 | General |
| Category: Cardiovascular | ||||||
| 08/17/2017 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $94.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 273 | 540 | $83,253 | $36,468 |
| 2022 | 6 | 234 | 402 | $63,223 | $25,993 |
| 2021 | 7 | 275 | 535 | $77,866 | $33,262 |
| 2020 | 7 | 306 | 637 | $102,078 | $44,719 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 122 | 351 | $49,140 | $21,155 | 43.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 88 | 93 | $17,577 | $8,086 | 46.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 22 | 23 | $8,165 | $3,063 | 37.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 21 | $3,948 | $1,919 | 48.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 19 | 41 | $2,993 | $1,564 | 52.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 11 | 11 | $1,430 | $680.24 | 47.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 91 | 233 | $32,620 | $12,783 | 39.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 73 | 75 | $14,175 | $6,087 | 42.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 15 | 16 | $5,680 | $2,438 | 42.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 15 | 26 | $4,888 | $2,085 | 42.7% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 18 | 30 | $3,000 | $1,517 | 50.6% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 22 | 22 | $2,860 | $1,084 | 37.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 111 | 316 | $44,240 | $18,047 | 40.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 67 | 67 | $12,663 | $5,664 | 44.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 26 | 60 | $11,280 | $4,868 | 43.2% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2021 | 25 | 36 | $3,600 | $2,038 | 56.6% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 22 | 22 | $2,860 | $1,267 | 44.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 13 | 13 | $1,690 | $732.03 | 43.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 11 | 21 | $1,533 | $646.28 | 42.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 119 | 393 | $55,020 | $23,317 | 42.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 43 | 82 | $15,416 | $7,002 | 45.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 75 | 80 | $15,120 | $6,923 | 45.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 32 | 33 | $11,715 | $5,216 | 44.5% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2020 | 11 | 16 | $1,600 | $866.11 | 54.1% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 14 | 14 | $1,820 | $778.07 | 42.8% |
About Dr. Justin Mccray, M.D
Dr. Justin Mccray, M.D is a Family Medicine healthcare provider based in Latrobe, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2008. The National Provider Identifier (NPI) number assigned to this provider is 1992968531.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Justin Mccray, M.D has received a total of $368.00 in payments from pharmaceutical and medical device companies, with $130.29 received in 2023. These payments were reported across 14 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($368.00).
As a Medicare-enrolled provider, Mccray has provided services to 1,088 Medicare beneficiaries, totaling 2,114 services with total Medicare billing of $140,443. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Student in an Organized Health Care Education/Training Program, Hospitalist
- Location Latrobe, PA
- Active Since 07/03/2008
- Last Updated 10/26/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1992968531
Products in Payments
- BYDUREON (Drug) $94.24
- DIFICID (Drug) $48.40
- BREZTRI (Drug) $46.59
- CAMZYOS (Drug) $35.65
- FARXIGA (Drug) $33.03
- BRILINTA (Drug) $32.86
- WATCHMAN Access System (Device) $25.04
- ENTRESTO (Drug) $21.77
- TEFLARO (Drug) $17.95
- ELIQUIS (Drug) $12.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Latrobe
Steven Selip, Md, MD
Family Medicine — Payments: $2,187
Matthew Woleslagle, D.o, D.O
Family Medicine — Payments: $1,682
Dr. Lindsey Beabout, D.o, D.O
Family Medicine — Payments: $1,542
David Yuna
Family Medicine — Payments: $1,047
David Ream, Md, MD
Family Medicine — Payments: $761.53
Donald Jakubek, Md, MD
Family Medicine — Payments: $350.24